Journal article

Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition


Authors listDony, E.; Lai, Y-J.; Dumitrascu, R.; Pullamsetti, S. S.; Savai, R.; Ghofrani, H. A.; Weissmann, N.; Schudt, C.; Fockerzi, D.; Seeger, W.; Grimminger, F.; Schermuly, R. T.

Publication year2008

Pages599-610

JournalEuropean Respiratory Journal

Volume number31

Issue number3

ISSN0903-1936

Open access statusBronze

DOI Linkhttps://doi.org/10.1183/09031936.00002007

PublisherEuropean Respiratory Society


Abstract

Phosphodiesterase (PDE) inhibitors are currently under investigation for the therapy of pulmonary hypertension.

The present study was designed to investigate chronic effects of oral pumafentrine, a mixed selective PDE-3/4 inhibitor, in monocrotaline (MCT)-induced pulmonary hypertension in rats.

Treatment with pumafentrine (10 mg(.)kg(-1) daily) from week 4 to 6 after a single injection of MCT (60 mg(.)kg(-1)) partially reversed pulmonary hypertension and right heart hypertrophy in rats. In addition, small pulmonary arterial muscularisation, media hypertrophy and decrease in lumen area were largely reversed. Inhibition of smooth muscle proliferation under pumafentrine was demonstrated in vivo as was a pro-apoptotic effect of pumafentrine on vascular cells. Moreover, pumafentrine dose-dependently increased cyclic adenosine monophosphate levels and inhibited proliferation of cultured pulmonary arterial smooth muscle cells.

In conclusion, oral pumafentrine partially reverses monocrotaline-induced pulmonary hypertension, lung vascular remodelling and right heart hypertrophy in rats.




Citation Styles

Harvard Citation styleDony, E., Lai, Y., Dumitrascu, R., Pullamsetti, S., Savai, R., Ghofrani, H., et al. (2008) Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition, European Respiratory Journal, 31(3), pp. 599-610. https://doi.org/10.1183/09031936.00002007

APA Citation styleDony, E., Lai, Y., Dumitrascu, R., Pullamsetti, S., Savai, R., Ghofrani, H., Weissmann, N., Schudt, C., Fockerzi, D., Seeger, W., Grimminger, F., & Schermuly, R. (2008). Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition. European Respiratory Journal. 31(3), 599-610. https://doi.org/10.1183/09031936.00002007



Keywords


CYCLIC-NUCLEOTIDE PHOSPHODIESTERASESINHALED PROSTACYCLINMONOCROTALINEPROSTACYCLIN ANALOGSremodellingSMOOTHSMOOTH-MUSCLE-CELLSTHYROID EPITHELIAL-CELLSVASODILATORY RESPONSE

Last updated on 2025-10-06 at 09:44